Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease

M. Sarno, L. Sarno, D. Baylink, B. Drinkwater, S. Farley, M. Kleerekoper, R. Lang, Joan M. Lappe, A. Licata, M. McClung, P. Miller, S. Nattrass, Robert R. Recker, E. N. Schwartz, J. R. Tucci, S. Wolf, H. Powell, G. Tjersland, G. Russell Warnick

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Convenient techniques for measuring rates of bone turnover have been developed in recent years with the advent of biochemical markers of bone metabolism. One recent of these techniques is a collection method and quantitative enzyme immunoassay for free pyridinoline crosslinks in human sweat. The concentrations of pyridinoline crosslinks in 5-day sweat collections and first morning void and 24-hour urine collections from healthy subjects and subjects with established metabolic bone disorders were determined. T-scores were higher in the sweat system than in the urine system by up to 10-fold in postmenopausal subjects, women with hyperparathyroidism, and subjects with postmenopausal osteoporosis. For subjects with postmenopausal osteoporosis, receiver-operating characteristic curve analysis yielded areas under the curve of 0.699, 0.629, and 0.520 for sweat pyridinoline, first morning void urine pyridinoline, and 24 hour urine pyridinoline respectively. The areas under the curve of the sweat and first morning void urine measurements were significantly greater (p

Original languageEnglish
Pages (from-to)223-228
Number of pages6
JournalClinical Chemistry and Laboratory Medicine
Volume39
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Sweat
Metabolic Bone Diseases
Healthy Volunteers
Bone
Urine
Postmenopausal Osteoporosis
Area Under Curve
Bone and Bones
Urine Specimen Collection
Hyperparathyroidism
Bone Remodeling
Immunoenzyme Techniques
Metabolism
ROC Curve
Biomarkers
pyridinoline
Enzymes

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease. / Sarno, M.; Sarno, L.; Baylink, D.; Drinkwater, B.; Farley, S.; Kleerekoper, M.; Lang, R.; Lappe, Joan M.; Licata, A.; McClung, M.; Miller, P.; Nattrass, S.; Recker, Robert R.; Schwartz, E. N.; Tucci, J. R.; Wolf, S.; Powell, H.; Tjersland, G.; Russell Warnick, G.

In: Clinical Chemistry and Laboratory Medicine, Vol. 39, No. 3, 2001, p. 223-228.

Research output: Contribution to journalArticle

Sarno, M, Sarno, L, Baylink, D, Drinkwater, B, Farley, S, Kleerekoper, M, Lang, R, Lappe, JM, Licata, A, McClung, M, Miller, P, Nattrass, S, Recker, RR, Schwartz, EN, Tucci, JR, Wolf, S, Powell, H, Tjersland, G & Russell Warnick, G 2001, 'Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease', Clinical Chemistry and Laboratory Medicine, vol. 39, no. 3, pp. 223-228. https://doi.org/10.1515/CCLM.2001.035
Sarno, M. ; Sarno, L. ; Baylink, D. ; Drinkwater, B. ; Farley, S. ; Kleerekoper, M. ; Lang, R. ; Lappe, Joan M. ; Licata, A. ; McClung, M. ; Miller, P. ; Nattrass, S. ; Recker, Robert R. ; Schwartz, E. N. ; Tucci, J. R. ; Wolf, S. ; Powell, H. ; Tjersland, G. ; Russell Warnick, G. / Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease. In: Clinical Chemistry and Laboratory Medicine. 2001 ; Vol. 39, No. 3. pp. 223-228.
@article{fe992c7d41e94f629031e74a6a9d10d4,
title = "Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease",
abstract = "Convenient techniques for measuring rates of bone turnover have been developed in recent years with the advent of biochemical markers of bone metabolism. One recent of these techniques is a collection method and quantitative enzyme immunoassay for free pyridinoline crosslinks in human sweat. The concentrations of pyridinoline crosslinks in 5-day sweat collections and first morning void and 24-hour urine collections from healthy subjects and subjects with established metabolic bone disorders were determined. T-scores were higher in the sweat system than in the urine system by up to 10-fold in postmenopausal subjects, women with hyperparathyroidism, and subjects with postmenopausal osteoporosis. For subjects with postmenopausal osteoporosis, receiver-operating characteristic curve analysis yielded areas under the curve of 0.699, 0.629, and 0.520 for sweat pyridinoline, first morning void urine pyridinoline, and 24 hour urine pyridinoline respectively. The areas under the curve of the sweat and first morning void urine measurements were significantly greater (p",
author = "M. Sarno and L. Sarno and D. Baylink and B. Drinkwater and S. Farley and M. Kleerekoper and R. Lang and Lappe, {Joan M.} and A. Licata and M. McClung and P. Miller and S. Nattrass and Recker, {Robert R.} and Schwartz, {E. N.} and Tucci, {J. R.} and S. Wolf and H. Powell and G. Tjersland and {Russell Warnick}, G.",
year = "2001",
doi = "10.1515/CCLM.2001.035",
language = "English",
volume = "39",
pages = "223--228",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "3",

}

TY - JOUR

T1 - Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease

AU - Sarno, M.

AU - Sarno, L.

AU - Baylink, D.

AU - Drinkwater, B.

AU - Farley, S.

AU - Kleerekoper, M.

AU - Lang, R.

AU - Lappe, Joan M.

AU - Licata, A.

AU - McClung, M.

AU - Miller, P.

AU - Nattrass, S.

AU - Recker, Robert R.

AU - Schwartz, E. N.

AU - Tucci, J. R.

AU - Wolf, S.

AU - Powell, H.

AU - Tjersland, G.

AU - Russell Warnick, G.

PY - 2001

Y1 - 2001

N2 - Convenient techniques for measuring rates of bone turnover have been developed in recent years with the advent of biochemical markers of bone metabolism. One recent of these techniques is a collection method and quantitative enzyme immunoassay for free pyridinoline crosslinks in human sweat. The concentrations of pyridinoline crosslinks in 5-day sweat collections and first morning void and 24-hour urine collections from healthy subjects and subjects with established metabolic bone disorders were determined. T-scores were higher in the sweat system than in the urine system by up to 10-fold in postmenopausal subjects, women with hyperparathyroidism, and subjects with postmenopausal osteoporosis. For subjects with postmenopausal osteoporosis, receiver-operating characteristic curve analysis yielded areas under the curve of 0.699, 0.629, and 0.520 for sweat pyridinoline, first morning void urine pyridinoline, and 24 hour urine pyridinoline respectively. The areas under the curve of the sweat and first morning void urine measurements were significantly greater (p

AB - Convenient techniques for measuring rates of bone turnover have been developed in recent years with the advent of biochemical markers of bone metabolism. One recent of these techniques is a collection method and quantitative enzyme immunoassay for free pyridinoline crosslinks in human sweat. The concentrations of pyridinoline crosslinks in 5-day sweat collections and first morning void and 24-hour urine collections from healthy subjects and subjects with established metabolic bone disorders were determined. T-scores were higher in the sweat system than in the urine system by up to 10-fold in postmenopausal subjects, women with hyperparathyroidism, and subjects with postmenopausal osteoporosis. For subjects with postmenopausal osteoporosis, receiver-operating characteristic curve analysis yielded areas under the curve of 0.699, 0.629, and 0.520 for sweat pyridinoline, first morning void urine pyridinoline, and 24 hour urine pyridinoline respectively. The areas under the curve of the sweat and first morning void urine measurements were significantly greater (p

UR - http://www.scopus.com/inward/record.url?scp=17744383983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744383983&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2001.035

DO - 10.1515/CCLM.2001.035

M3 - Article

C2 - 11350019

AN - SCOPUS:17744383983

VL - 39

SP - 223

EP - 228

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 3

ER -